Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.

Bashir B, Merlino DJ, Rappaport JA, Gnass E, Palazzo JP, Feng Y, Fearon ER, Snook AE, Waldman SA.

Hum Pathol. 2019 May;87:103-114. doi: 10.1016/j.humpath.2018.11.032. Epub 2019 Feb 2.

PMID:
30716341
2.

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H.

Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4.

PMID:
30528798
3.

A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer.

Ye Z, Wang C, Guo L, Palazzo JP, Han Z, Lai Y, Jiang J, Posey JA, Mallick AB, Li B, Jiang L, Yang H.

J Natl Compr Canc Netw. 2018 Oct;16(10):1183-1192. doi: 10.6004/jnccn.2018.7048.

PMID:
30323088
4.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
5.

Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.

Wei Q, Ye Z, Zhong X, Li L, Wang C, Myers RE, Palazzo JP, Fortuna D, Yan A, Waldman SA, Chen X, Posey JA, Basu-Mallick A, Jiang BH, Hou L, Shu J, Sun Y, Xing J, Li B, Yang H.

Ann Oncol. 2017 Sep 1;28(9):2135-2141. doi: 10.1093/annonc/mdx278.

6.

Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience.

Nam K, Eisenbrey JR, Stanczak M, Sridharan A, Berger AC, Avery T, Palazzo JP, Forsberg F.

Radiology. 2017 Oct;285(1):53-62. doi: 10.1148/radiol.2017161683. Epub 2017 May 3.

7.

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H.

Breast Cancer Res Treat. 2017 Jan;161(1):83-94. doi: 10.1007/s10549-016-4026-2. Epub 2016 Oct 22.

PMID:
27771841
8.

Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?

Tatarian T, Sokas C, Rufail M, Lazar M, Malhotra S, Palazzo JP, Hsu E, Tsangaris T, Berger AC.

Ann Surg Oncol. 2016 Aug;23(8):2501-7. doi: 10.1245/s10434-016-5182-7. Epub 2016 Mar 9.

PMID:
26960929
9.

Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.

Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H.

Gastroenterology. 2016 May;150(5):1135-1146. doi: 10.1053/j.gastro.2016.01.030. Epub 2016 Feb 2.

10.

Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.

Mardekian SK, Bombonati A, Palazzo JP.

Hum Pathol. 2016 Mar;49:114-23. doi: 10.1016/j.humpath.2015.11.003. Epub 2015 Nov 17. Review.

PMID:
26826418
11.

Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.

Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M.

Breast Cancer Res Treat. 2015 Dec;154(3):563-71. doi: 10.1007/s10549-015-3636-4. Epub 2015 Nov 16.

PMID:
26573830
12.

The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.

Lai Y, Ye Z, Civan JM, Wang C, Cristofanilli M, Mu Z, Austin L, Palazzo JP, Myers RE, Yang H.

Breast Cancer Res Treat. 2015 Sep;153(2):407-16. doi: 10.1007/s10549-015-3532-y. Epub 2015 Aug 12.

PMID:
26264468
13.

Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.

Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.

Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3816-25. doi: 10.1073/pnas.1510077112. Epub 2015 Jun 29.

14.

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.

Gatalica Z, Bilalovic N, Palazzo JP, Bender RP, Swensen J, Millis SZ, Vranic S, Von Hoff D, Arceci RJ.

Oncotarget. 2015 Aug 14;6(23):19819-25.

15.

Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables.

Wang C, Civan J, Lai Y, Cristofanilli M, Hyslop T, Palazzo JP, Myers RE, Li B, Ye Z, Zhang K, Xing J, Yang H.

Cancer Causes Control. 2015 Jan;26(1):45-56. doi: 10.1007/s10552-014-0481-4. Epub 2014 Oct 31.

PMID:
25359303
16.

Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.

Lai Y, Palazzo JP, Cristofanilli M, Hyslop T, Civan J, Avery T, Myers RE, Li B, Ye Z, Xing J, Yang H.

Breast Cancer Res Treat. 2014 Nov;148(1):175-85. doi: 10.1007/s10549-014-3152-y. Epub 2014 Sep 27.

PMID:
25261294
17.

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers.

Wan S, Lai Y, Myers RE, Li B, Palazzo JP, Burkart AL, Chen G, Xing J, Yang H.

BMC Cancer. 2013 Jul 10;13:340. doi: 10.1186/1471-2407-13-340.

18.

Impact of Oncotype DX on treatment decisions in ER-positive, node-negative breast cancer with histologic correlation.

Biroschak JR, Schwartz GF, Palazzo JP, Toll AD, Brill KL, Jaslow RJ, Lee SY.

Breast J. 2013 May-Jun;19(3):269-75. doi: 10.1111/tbj.12099.

PMID:
23614365
19.

Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.

Ye Z, Palazzo JP, Lin L, Lai Y, Guiles F, Myers RE, Han J, Xing J, Yang H.

J Gastroenterol Hepatol. 2013 Sep;28(9):1469-75. doi: 10.1111/jgh.12237.

20.

Acinar cell cystadenoma of the pancreas: report of three cases and literature review.

Wolf AM, Shirley LA, Winter JM, Prestipino AJ, Palazzo JP, Yeo CJ, Lavu H.

J Gastrointest Surg. 2013 Jul;17(7):1322-6. doi: 10.1007/s11605-013-2199-0. Epub 2013 Apr 19. Review.

PMID:
23605178
21.

Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients.

Wan S, Lai Y, Myers RE, Li B, Hyslop T, London J, Chatterjee D, Palazzo JP, Burkart AL, Zhang K, Xing J, Yang H.

J Gastrointest Cancer. 2013 Sep;44(3):293-304. doi: 10.1007/s12029-013-9491-9.

22.

Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection.

Dai J, Wan S, Zhou F, Myers RE, Guo X, Li B, Fu X, Palazzo JP, Dou K, Yang H, Xing J.

PLoS One. 2012;7(4):e34758. doi: 10.1371/journal.pone.0034758. Epub 2012 Apr 4.

23.

AIRP best cases in radiologic-pathologic correlation: spindle cell carcinoma of the esophagus.

Sadej P, Feld RI, Toll AD, Palazzo JP.

Radiographics. 2011 Nov-Dec;31(7):2035-9. doi: 10.1148/rg.317105214. No abstract available.

PMID:
22084186
24.

Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer.

Xing J, Wan S, Zhou F, Qu F, Li B, Myers RE, Fu X, Palazzo JP, He X, Chen Z, Yang H.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):217-27. doi: 10.1158/1055-9965.EPI-11-0624. Epub 2011 Oct 25.

25.

Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase.

Toll AD, Boman BM, Palazzo JP.

Hum Pathol. 2012 Feb;43(2):238-42. doi: 10.1016/j.humpath.2011.04.026. Epub 2011 Aug 4.

PMID:
21820149
26.

Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone.

Holmes P, Lloyd J, Chervoneva I, Pequinot E, Cornfield DB, Schwartz GF, Allen KG, Palazzo JP.

Cancer. 2011 Aug 15;117(16):3650-7. doi: 10.1002/cncr.25942. Epub 2011 Feb 11.

27.

Parametric imaging using subharmonic signals from ultrasound contrast agents in patients with breast lesions.

Eisenbrey JR, Dave JK, Merton DA, Palazzo JP, Hall AL, Forsberg F.

J Ultrasound Med. 2011 Jan;30(1):85-92.

28.

Assessment of immunohistochemistry for p16INK4 and high-risk HPV DNA by in situ hybridization in esophageal squamous cell carcinoma.

Malik SM, Nevin DT, Cohen S, Hunt JL, Palazzo JP.

Int J Surg Pathol. 2011 Feb;19(1):31-4. doi: 10.1177/1066896910382005. Epub 2010 Nov 17.

PMID:
21087981
29.

Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development.

Zhang T, Fields JZ, Opdenaker L, Otevrel T, Masuda E, Palazzo JP, Isenberg GA, Goldstein SD, Brand M, Boman BM.

Am J Pathol. 2010 Dec;177(6):2816-26. doi: 10.2353/ajpath.2010.100047. Epub 2010 Nov 5.

30.

Prognostic significance of high-grade dysplasia in colorectal adenomas.

Toll AD, Fabius D, Hyslop T, Pequignot E, DiMarino AJ, Infantolino A, Palazzo JP.

Colorectal Dis. 2011 Apr;13(4):370-3. doi: 10.1111/j.1463-1318.2010.02385.x.

PMID:
20718835
31.

Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.

Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP.

Cancer. 2010 Mar 1;116(5):1243-51. doi: 10.1002/cncr.24887.

32.

Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms.

Ciocca V, Bombonati A, Palazzo JP, Schulz S, Waldman SA.

Histopathology. 2009 Aug;55(2):182-8. doi: 10.1111/j.1365-2559.2009.03358.x.

33.

MicroRNA expression profiling of male breast cancer.

Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A.

Breast Cancer Res. 2009;11(4):R58. doi: 10.1186/bcr2348. Epub 2009 Aug 10.

34.

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A.

J Pathol. 2009 Oct;219(2):214-21. doi: 10.1002/path.2586.

PMID:
19593777
35.

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ; Consensus Conference Committee, Anderson BO, Arun BK, Bartelink H, Bernard P, Bonanni B, Cady B, Clough KB, Feig SA, Heywang-Köbrunner SH, Howell A, Isaacs C, Kopans DB, Mansel RE, Masood S, Palazzo JP, Pressman PI, Solin LJ, Untch M.

Breast J. 2009 Jan-Feb;15(1):4-16. doi: 10.1111/j.1524-4741.2008.00665.x.

36.

Diffuse colitis cystica profunda in a patient with ulcerative colitis.

Toll AD, Palazzo JP.

Inflamm Bowel Dis. 2009 Oct;15(10):1454-5. doi: 10.1002/ibd.20832. No abstract available.

PMID:
19097229
37.

Molecular grading of ductal carcinoma in situ of the breast.

Balleine RL, Webster LR, Davis S, Salisbury EL, Palazzo JP, Schwartz GF, Cornfield DB, Walker RL, Byth K, Clarke CL, Meltzer PS.

Clin Cancer Res. 2008 Dec 15;14(24):8244-52. doi: 10.1158/1078-0432.CCR-08-0939.

38.

The significance of GATA3 expression in breast cancer: a 10-year follow-up study.

Ciocca V, Daskalakis C, Ciocca RM, Ruiz-Orrico A, Palazzo JP.

Hum Pathol. 2009 Apr;40(4):489-95. doi: 10.1016/j.humpath.2008.09.010. Epub 2008 Dec 11.

PMID:
19084267
39.

Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breast.

Schwartz GF, Krill LS, Palazzo JP, Dasgupta A.

J Am Coll Surg. 2008 Nov;207(5):758-62. doi: 10.1016/j.jamcollsurg.2008.06.341. Epub 2008 Aug 23.

PMID:
18954790
40.

MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer.

Vecchione A, Fassan M, Anesti V, Morrione A, Goldoni S, Baldassarre G, Byrne D, D'Arca D, Palazzo JP, Lloyd J, Scorrano L, Gomella LG, Iozzo RV, Baffa R.

Oncogene. 2009 Jan 15;28(2):257-69. doi: 10.1038/onc.2008.381. Epub 2008 Oct 20.

41.

Primary mucosa-associated lymphoid tissue lymphoma of the breast.

Rajendran RR, Palazzo JP, Schwartz GF, Glick JH, Solin LJ.

Clin Breast Cancer. 2008 Apr;8(2):187-8. doi: 10.3816/CBC.2008.n.020.

PMID:
18621616
42.

Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity.

Forsberg F, Kuruvilla B, Pascua MB, Chaudhari MH, Merton DA, Palazzo JP, Goldberg BB.

Ultrasound Med Biol. 2008 Sep;34(9):1365-72. doi: 10.1016/j.ultrasmedbio.2008.02.010. Epub 2008 Apr 24.

43.

Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.

Plotnikov A, Li Y, Tran TH, Tang W, Palazzo JP, Rui H, Fuchs SY.

Cancer Res. 2008 Mar 1;68(5):1354-61. doi: 10.1158/0008-5472.CAN-07-6094.

44.

Is single-cell apoptosis sufficient for the diagnosis of graft-versus-host disease in the colon?

Nguyen CV, Kastenberg DM, Choudhary C, Katz LC, DiMarino A, Palazzo JP.

Dig Dis Sci. 2008 Mar;53(3):747-56. Epub 2007 Dec 1.

PMID:
18060495
45.

An audit of endoscopic complications in adult eosinophilic esophagitis.

Cohen MS, Kaufman AB, Palazzo JP, Nevin D, Dimarino AJ Jr, Cohen S.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1149-53. Epub 2007 Aug 1. Review.

PMID:
17683993
46.

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.

Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y, Baran AA, Siracusa LD, Pitari GM, Waldman SA.

Gastroenterology. 2007 Aug;133(2):599-607. Epub 2007 Jun 2.

PMID:
17681179
47.

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM.

Genome Biol. 2007;8(5):R76.

48.

Cytokeratin profiles of male breast cancers.

Ciocca V, Bombonati A, Gatalica Z, Di Pasquale M, Milos A, Ruiz-Orrico A, Dreher D, Folch N, Monzon F, Santeusanio G, Perou CM, Bernard PS, Palazzo JP.

Histopathology. 2006 Oct;49(4):365-70.

PMID:
16978199
49.

Proceedings of the consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005.

Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, Holland R, Hughes KS, Mansel RE, Margolese R, Mendelson EB, Olivotto IA, Palazzo JP, Solin LJ; Consensus Conference Committee.

Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1281-8. No abstract available.

PMID:
16924719
50.

Consensus conference on breast conservation.

Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, Holland R, Hughes KS, Mansel RE, Margolese R, Mendelson EB, Olivotto IA, Palazzo JP, Solin LJ; Consensus Conference Committee.

J Am Coll Surg. 2006 Aug;203(2):198-207. No abstract available.

PMID:
16864033

Supplemental Content

Loading ...
Support Center